Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D LEVIN

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Breast Cancer Research and Treatment|January 4, 2021
Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?N I Bouwer, T G Steenbruggen, J van Rosmalen, et al.
ESMO Open|January 31, 2025
The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapyZ L R Kaplan, N van Leeuwen, D van Klaveren, et al.
British Journal of Haematology|November 3, 2025
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myelomaM R Seefat, D G J Cucchi, L van Boven, et al.
European Journal of Haematology|February 17, 2025
Treatment-Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical Cohort of CML PatientsC Kockerols, P J M Valk, P Hogenbirk, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2024
Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trialM R Seefat, C A M Stege, B I Lissenberg-Witte, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Breast Cancer Research and Treatment|January 4, 2021
Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?N I Bouwer, T G Steenbruggen, J van Rosmalen, et al.
ESMO Open|January 31, 2025
The association between hospital volume and overall survival in adult AML patients treated with intensive chemotherapyZ L R Kaplan, N van Leeuwen, D van Klaveren, et al.
British Journal of Haematology|November 3, 2025
Pharmacokinetic and pharmacodynamic evaluation of alternative pomalidomide dosing regimens in the treatment of multiple myelomaM R Seefat, D G J Cucchi, L van Boven, et al.
European Journal of Haematology|February 17, 2025
Treatment-Free Remission Outcomes in a BCR::ABL1 Digital PCR Selected Clinical Cohort of CML PatientsC Kockerols, P J M Valk, P Hogenbirk, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2024
Quality of life gains in frail and intermediate-fit patients with multiple Myeloma: Findings from the prospective HOVON123 clinical trialM R Seefat, C A M Stege, B I Lissenberg-Witte, et al.
Pageof 5